REFERENCES 1Stegemann MR et al. Clinical efficacy and safety of cefovecin in the treatment of canine pyoderma and wound infections. J Small Animal Practice 2007; 48(7), 378-86 2Six R et al. Efficacy and safety of cefovecin in treating bacterial folliculitis, abscesses or infected wounds in dogs. J Am Vet Med Assoc 2008; 233, 433-39. Pfizer study number 1163C-60-00-468
It is prudent to reserve 3rd-generation cephalosporins for clinical conditions responding poorly or expected to respond poorly to other classes of antimicrobials or 1st-generation cephalosporins. Convenia use should be based on susceptibility testing.